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Proliferating cell nuclear antigen is required for
loading of the SMCX/KMD5C histone
demethylase onto chromatin
Zhihui Liang1,5, Marc Diamond1,6, Johanna A Smith1, Matthias Schnell2 and René Daniel1,3,4*
Abstract
Background: Histone methylation is regulated by a large number of histone methyltransferases and demethylases.
The recently discovered SMCX/KMD5C demethylase has been shown to remove methyl residues from lysine 4 of
histone H3 (H3K4), and constitutes an important component of the regulatory element-1-silencing transcription
factor (REST) protein complex. However, little is known about the cellular mechanisms that control SMCX activity
and intracellular trafficking.
Results: In this study, we found that small interfering RNA-mediated knockdown of proliferating cell nuclear
antigen (PCNA) resulted in the reduction of the chromatin-bound SMCX fraction. We identified a PCNA-interaction
protein motif (PIP box) in the SMCX protein. Using site-directed mutagenesis, we found that the amino acids of
the SMCX PIP box are involved in the association of SMCX with PCNA and its interaction with chromatin.
Conclusions: Our data indicate that the intracellular trafficking of SMCX is controlled by its association with PCNA.
Background
Cellular DNA in eukaryotes is organized in chromatin,
which contains a multitude of proteins. Histone proteins
comprise a major structural component of chromatin.
Histones carry diverse post-translational modifications,
particularly on the lysines of their N-terminus. These
modifications include methylation, acetylation, ubiquity-
lation and phosphorylation [1-4]. Histone modifications
are involved in crucial cellular processes, including tran-
scription, DNA replication, and the DNA-damage
response [1,3,5]. As might be expected, chromatin and
histones undergo major reorganization during DNA
replication. After replication, the appropriate chromatin
structure has to be restored in order to maintain the pas-
sage of information from mother to daughter cells.
One of the major histone modifications is methylation
of the lysine 4 residue of histone H3 (H3K4). Trimethyla-
tion of H3K4 is a hallmark of active transcription, and
conversely, a loss of this modification represses transcrip-
tion. Histone methylation is a very stable modification
compared with, for example, acetylation. It had been long
thought that this modification was irreversible [6]. This
was supported by the fact that histone methyltransferases
were identified, but their counterparts, histone demethy-
lases, were not yet known. This situation changed with
the first discovery of a histone demethylase, termed
lysine-specific demethylase (LSD)1 [7]. LSD1 prefers dou-
ble-methylated H3K4 as its substrate [7]. Following this
discovery, many other histone demethylases were discov-
ered, with various preferences for specific methylated his-
tone residues. One of the newly discovered demethylases
is SMCX (Smcy homolog, X-linked (mouse); also termed
lysine-specific demethylase 5C (KDM5C) and jumonji,
AT rich interactive domain 1C (JARID1C)) [8].
SMCX is a ubiquitously expressed protein, which has
been linked to mental retardation [9-14]. In addition, a
novel mutation in the SMCX gene was found in a patient
with autism spectrum disorder (ASD) [15]. SMCX con-
tains a JmjC domain, and belongs to a family of demethy-
lases, which includes the Y-linked homolog SMCY,
retinoblastoma binding protein (RBP)2, and; lysine-specific
demethylase 5B (KDM5B; also termed PLU-1) [8,16]. In
addition to JmjC, SMCX also contains the N-terminal
plant homeodomain (PHD) finger, which binds to the
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trimethylated H3K4 (H3K4me3). SMCX reverses H3K4
me3 to di- and mono-, but not unmethylated products [8].
SMCX was reported to function as a transcriptional
repressor, and its loss impairs neuronal gene regulation
mediated by regulatory element-1-silencing transcription
factor (REST) [17,18]. However, little is known about how
the SMCX-mediated demethylase activity is regulated dur-
ing the cell cycle and other crucial cellular processes.
In this study, we found that SMCX-mediated H3K4
demethylation is regulated by proliferating cell nuclear
antigen (PCNA). We show that association of SMCX with
chromatin and H3K4me3 demethylation depends on
PCNA. Further, we identified a aconserved sequence
motif, [NQ]xx(L/I/M/V)xx (F/Y/W), called the PCNA-
interaction protein motif (PIP box) in the SMCX protein.
Finally, site-directed mutagenesis demonstrates that the
PIP box is important for SMCX association with PCNA.
Methods
Cells, plasmids and PIP BOX mutants
We used 293T/17 cells (referred to as ‘293T’ from this
point onwards) (catalog number CRL-11268; American
Type Culture Collection (ATCC) Manassas, VA, USA),
which were maintained in DMEM medium supplemented
with 10% FBS and antibiotics (Penn/Strep at 1:100).
A pCMV6-XL6 vector with SMCX cDNA was used
(Origene Technologies, Rockville, MD, USA and expressed
from the cytomegalovirus (CMV) promoter (number
SC128277;). The PIP box in SMCX and G9a were identi-
fied using a ScanProsite search for conserved motifs in
SMCX and G9a sequences. PIP box mutants were
obtained by site-directed mutagenesis of the SMCX-
encoding plasmid of residues F, L and Q, respectively, into
A, and confirmed using sequencing and other standard
methods.
Transfections
Regularly maintained 293T cells were plated into cell-cul-
ture dishes with DMEM and 10% inactivated FBS, 1 day
before transfection. The following day, the plates were
transfected using Lipofectamine™ 2000 (number
11668027; Invitrogen Corp., Carlsbad, CA, USA), when
transfected with small interfering (si)RNA and plasmid
DNA, or Lipofectamine™ RNAiMAX (number
13778075; Invitrogen Corp.) when transfected with
siRNA (targeting PCNA) alone.
Small interfering RNAs
Pools of PCNA siRNA, G9a siRNA and the non-targeting
control siRNA sequences were synthesized (numbers M-
003289-02-0010, M-006937-01-0005 and P-001206-13-
05 respectively; Dharmacon Research Inc., Lafayette, CO,
USA). To deplete PCNA, 293T cells were transfected
twice (Lipofectamine™ 2000) with the indicated siRNAs
at 24-hour intervals. Cells were subsequently harvested at
48 hours after the first transfection, and lysed for immu-
noblotting experiments.
Antibodies and beads
The antibodies used were: anti-histone H3 (number
ab1791-100), anti-SMCX (number ab72152 for Figures 1,
2 and 3, and ab34718 for Figures 4 and 5), a and anti-
H3K4me3 (number ab8580) (all Abcam, Cambridge, Cam-
bridgeshire, UK); anti-PCNA (number sc-56), Trim5
(number sc-48319) and anti-GAPDH (number sc-2037)
(all Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA);
Anti-BrdU conjugated to Alexa Fluor 594 (number
A21304) and secondary donkey anti-rabbit conjugated to
Alexa Fluor 488 (number A21206) (both Invitrogen Corp).
Preparation of chromatin fractions and western blotting
The cells were washed with PBS once, then pelleted by
centrifugation. Pellets were resuspended in lysis buffer
with 1% Triton X-100 and fresh protease inhibitors, and
incubated on ice for 5 minutes. Lysates were then sepa-
rated by centrifugation at 13,000 rpm for 5 minutes. The
resulting supernatant contained cytoplasmic and nuclear
SMCX
PCNA
H3
H3K4me3
Trim5?
Figure 1 Effect of proliferating cell nuclear antigen (PCNA)
knockdown on the intracellular distribution of exogenous
SMCX (Smcy homolog, X-linked (mouse)) protein. 293T cells
were transfected with the SMCX-encoding plasmid or the control
empty vector, and PCNA or control small interfering (si)RNA. Two
days after transfection, cells were harvested, then the chromatin
fraction was separated from the rest of the lysate and the fractions
analyzed by western blotting. The four samples on the left are of
SMCX and PCNA levels in chromatin, and those on the right are
SMCX levels in the whole-cell lysate without chromatin fraction.
Histone H3 (chromatin protein) and TRim5a (cytoplasmic protein),
respectively, were used as loading controls. The label ‘Vector’
indicates cells transfected with the empty plasmid vector.
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proteins without the chromatin fraction. The chromatin-
containing pellet was resuspended in the sample buffer
containing SDS, and denatured by heating at 90°C for 10
minutes; it was then incubated on ice for 5 minutes.
Before loading onto SDS-PAGE gels, samples were treated
with sonication to break up DNA, and separated by centri-
fugation. After electrophoresis, samples were transferred
to a membrane (Immobilon P; number IPVH00010; Milli-
pore, Billerica, MA, USA), and incubated with primary
and secondary antibodies in 5% milk. The Santa Cruz anti-
bodies were diluted 1:200, and all other antibodies were
diluted 1:1000. All secondary antibodies were diluted
1:5000. Bands were detected using chemiluminescence.
Immunoprecipitation
The cells were harvested and chromatin lysates prepared
as described previously [19]. The immunoprecipitation
was carried out at 4°C overnight by incubating the lysates
with the primary antibody of interest or a normal IgG
(Santa Cruz, rabbit IgG sc2027, mouse IgG sc-2025). The
after day, protein-antibody complexes were isolated by
binding to protein G plus/protein A agarose (number
IP05; Calbiochem-Novabiochem International, Inc., La
Jolla, CA, USA). for 1 hour at 4°C. Immunoprecipitates
were collected and washed 3 times with the lysis buffer,
resuspended in the SDS sample buffer and heated for
5 minutes at 90°C. The protein G plus/protein A agarose
SMCX (Ch)
PCNA
H3
SMCX (W-Ch)
Figure 2 Effect of proliferating cell nuclear antigen (PCNA)
knockdown on intracellular distribution of endogenous SMCX
(Smcy homolog, X-linked (mouse)) protein. 293T cells were
transfected with anti-PCNA or control small interfering (si)RNA. Two
days after transfection, cells were harvested, then the chromatin
fraction was separated from the rest of the lysate and fractions
analyzed by western blotting. Ch = chromatin fraction, W-Ch = cell
lysate without chromatin.
H3
SMCX
(W-Ch)
H3
SMCX
(Ch)
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(Ch)
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Figure 3 Cell-cycle regulation of SMCX (Smcy homolog, X-linked (mouse)). (A) SMCX levels in cells treated with and stained for (5-bromo-
2’-deoxyuridine, BrdU). Cells were exposed to BrdU for 3 hours then double-stained with anti-BrdU and SMCX antibodies. Representative cells
(high or low BrdU staining) are shown. Top two rows show cells exhibiting the granular pattern. (B) SMCX DNA was transfected into cells, and 2
days after transfection cells were synchronized with aphidicolin. One day later, cells were released from the aphidicolin block, and SMCX levels
were monitored at indicated intervals using western blotting. (C) This experiment was designed as in (B), except that transfection was not
performed and endogenous SMCX levels were monitored. Cyclin A = cyclin A levels, a cell-cycle synchronization control; cyclin A levels increase
in late G1 and stay high through the S phase. H3 = histone H3, a loading control for the chromatin fraction. Other terminology as in Figure 5.
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was removed by centrifugation. The samples were then
loaded onto SDS-PAGE and processed as described above
for western blotting. The DNAse pre-treatment was per-
formed as described previously [19].
Immunofluorescence
293T cells were plated onto four-well slides (Lab Tek
Chamber;Thermo Scientific, Rochestyer NY)] at a density
of 4 × 105 per well. The next day cells were exposed to
BrdU for 3 hours at a concentration of 10 μmol/L. Cells
were washed once with PBS and then fixed with cold
methanol for 20 minutes. DNA was then denatured by
two consecutive treatments with 4 mol/L HCL for 15 min-
utes each. Cells were then washed with PBS and incubated
with antibodies diluted 1:50 in PBS with 3% BSA (anti-
BrdU conjugated to Alexa Fluor 594 and anti-SMCX, or a
control with no antibody) overnight at 4°C. The next day,
cells were washed with PBS containing Tween 20, and
then incubated with a secondary donkey anti-rabbit anti-
body targeting SMCX (controls consisted of a well with no
antibody, or a well with secondary antibody alone; data not
shown) in PBS with 3% BSA for 1 hour at room tempera-
ture. Cells were then washed with PBS with 3% BSA, then
incubated with DAPI for 5 minutes, then mounted with
antifade reagent (number P36930; ProLong® Gold; Invi-
trogen Corp.) and cured overnight before pictures were
taken (Eclipse TE-2000S; Nikon, Tokyo, Japan).
Synchronization experiments
293T cells were plated onto 60 mm dishes and tranfected
with the SMCX plasmid as described above. Two days
after transfection, aphidicolin was added to a final concen-
tration of 5 mg/ml. One day later, the aphidicolin-contain-
ing medium was removed and cells washed. Standard
medium was added, then cells were harvested at the indi-
cated intervals and analyzed by western blotting. The
experiment described in Figure 3C was performed in a
similar manner, except that cells were not transfected with
the SMCX plasmid.
Results
Association of overexpressed SMCX in chromatin depends
on proliferating cell nuclear antigen
Because endogenous SMCX expression is reported to be
low in most types of somatic cells, except neurons [8], we
initially used an overexpression approach and transiently
overexpressed SMCX under control of the CMV promo-
ter. Overexpressed SMCX was found to be present in both
whole-cell lysates and the chromatin fraction (Figure 1),
but the levels in chromatin, although still significant, were
lower than those in the whole-cell lysates.
We then treated cells with siRNA targeting PCNA.
PCNA knockdown strikingly reduced the amount of
SMCX in chromatin (Figure 1). Control siRNA did not
affect SMCX levels in the chromatin fraction, and PCNA
siRNA did not significantly affect the overall SMCX
levels in the whole-cell lysate (results were quantified by
densitometry, data not shown). H3K4me3 levels inversely
correlated with SMCX levels in chromatin. Our results
thus show that PCNA is required for the entry of exogen-
ous SMCX into chromatin.
Association of endogenous SMCX with chromatin also
depends on PCNA
293T cells do express SMCX, although at very low levels.
Large amounts of protein lysate are required to detect
endogenous SMCX by western blotting. Thus, to investi-
gate whether our conclusions can be extended to endo-
genous SMCX, we transfected 293T cells with PCNA
siRNA, and examined the levels of endogenous SMCX in
chromatin. DNA knockdown also reduced levels of endo-
genous SMCX (Figure 2). This result also supports our
initial conclusion that PCNA is required for SMCX asso-
ciation with chromatin.
SMCX associates with proliferating cell nuclear antigen
PCNA carries binding sites for a large number of tran-
scription factors and other chromatin-associated
PCNA
SMCX
In P D Ig
In S D Ig
Figure 4 Association of SMCX (Smcy homolog, X-linked
(mouse)) and proliferating cell nuclear antigen (PCNA). 293T
cells were transfected with the SMCX-encoding plasmid, and
chromatin lysates prepared 2 days after transfection. Lysates were
then immunoprecipitated with anti-SMCX, anti-PCNA, or control
normal rabbit or mouse IgG, respectively. Some lysates were
pretreated with DNAse, as described in Methods. SMCX and PCNA
were detected by western blotting. D = DNAse-pretreated samples,
immunnoprecipitated with the corresponding antibody, Ig = control
normal IgG (mouse for the anti-PCNA antibody (top), and rabbit for
the anti-SMCX antibody (bottom)), In = input lysate, P = samples
immunoprecipitated with the anti-PCNA antibody, S = samples
immunoprecpitated with the anti-SMCX antibody.
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Figure 5 Association with proliferating cell nuclear antigen (PCNA) and Intracellular distribution of SMCX (Smcy homolog, X-linked
(mouse)) PCNA-interaction protein motif (PIP box) mutants. (A) Intracellular distribution of PIP mutants. 293T cells were transfected with
plasmid encoding SMCX and mutated SMCX Two days after transfection, cells were harvested, then the chromatin fraction was separated from
the rest of the lysate and both fractions analyzed by western blotting. SMCX mutants in chromatin: SMCX = normal SMCX, F1209A = F to A
mutant (see text), L1204A = L to A mutant, Q1201A = Q to A mutant. H3 and GAPDH served as loading controls. Ch = chromatin fraction, W-Ch
= cell lysate without chromatin (bottom), (B) Association of PIP mutants with PCNA 293T cells were transfected as in (A). Two days after
transfection, cells were harvested, whole-cell lysates prepared and immunoprecipitated with PCNA. SMCX and PIP mutants in
immunoprecipitates were detected using western blotting. Terminology as in (A).
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proteins [20]. We hypothesized that SMCX may associ-
ate with PCNA, similar to other proteins that affect
chromatin structure. To test this hypothesis, we per-
formed co-immunoprecipitation experiments and ana-
lyzed SMCX levels in PCNA immunoprecipitates of the
chromatin fraction and vice versa. SMCX co-immuno-
precipitates with PCNA (Figure 4), and thus we con-
clude that SMCX associates with PCNA.
We also tested the hypothesis that the PCNA-SMCX
interaction is mediated by DNA. Thus, samples were pre-
treated by DNAse, as described previously [19]. The treat-
ment did not affect the levels of co-immunoprecipitated
SMCX or PCNA., indicating that SMCX-PCNA co-immu-
noprecipitation reflects protein-protein interaction.
SMCX contains a PIP box
The PIP box,[NQ]xx(L/I/M/V)xx (F/Y/W), is found in
some PCNA-interacting proteins, such as the p21 (WAF1/
CIP1) protein [20,21], and it interacts with the interdo-
main connector loop (IDCL) of PCNA. Because PCNA is
a homotrimer, it is possible that complexes containing up
to three PCNA-interacting proteins can be assembled on a
single PCNA ring. For example, each of the subunits in a
human PCNA trimer can simultaneously bind to a differ-
ent flap endonuclease (FEN)-1 molecule [22,23].
Another novel PCNA-binding motif, K-A-(A/L/I)-(A/
L/Q)-x-x-(L/V), is termed the KA box. It is distinct
from the ‘classic’ PIP box and is also present in several
PCNA-interacting proteins [20]. To determine if SMCX
contains either of these PCNA-interacting motifs, we
performed an analysis of the SMCX protein sequence
using the ScanProsite program. We identified a PIP box
in the SMCX protein (Figure 6A): - - Q- - L- - -WF- -.
The full amino acid sequence is: - -QCDLCQDWF- -.
PIP box in proteins of the regulatory element-1-silencing
transcription factor complex
We then tested a hypothesis that SMCX association with
PCNA is indirect, and is mediated by another protein,
rather than the SMCX PIP box. Because SMCX is a com-
ponent of a protein complex that contains REST, the his-
tone deacetylases HDAC1 and HDAC2, and the histone
methyltransferase G9a, we analyzed these proteins for the
presence of a PIP box motif, and found one in the G9a
protein (Figure 6B). The motif is of the type found in
SMCX. This finding prompted tanother question: does
PCNA bring SMCX into chromatin directly, or is SMCX
brought into chromatin by interacting with G9a, which in
turn interacts directly with PCNA?
To address this issue, we knocked down G9a in 293T
cells using siRNA. We found that G9a knockdown did not
affect chromatin levels of SMCX (see Additional file 1, Fig-
ure S1), supporting the hypothesis that the entry of SMCX
into chromatin is due to direct interaction with PCNA.
SMCX PIP box mutants exhibit reduced association with
chromatin
To test the hypothesis that the putative SMCX PIP box
mediates the interaction with PCNA and loading SMCX
onto chromatin, we mutated three of the conserved resi-
dues within the PIP box (F, L and Q; Figure 6), and inves-
tigated whether these mutant proteins associate with
PCNA and chromatin. We found that mutations of F to A,
L to A and Q to A all led to reduced co-immunoprecipita-
tion of SMCX and PCNA (Figure 5B), Similarly, all three
mutants were reduced in chromatin compared with nor-
mal SMCX (Figure 5A). We conclude that the amino
acids of the SMCX PIP box control the interaction of
SMCX with PCNA and the loading of SMCX onto
chromatin.
SMCX association with proliferating cell nuclear antigen is
regulated by the cell cycle
PCNA is mainly expressed in S phase. To determine if
SMCX levels similarly fluctuate inside cells during the cell
cycle, we performed immunofluorescence experiments,
and found that SMCX was expressed both in cells with
strong staining with anti-BrdU antibody (S phase) and in
cells showing very little BrdU staining (Figure 3A). How-
ever, SMCX in S phase cells had a different, granular pat-
tern of distribution compared with other cells. This result
suggests a possible SMCX redistribution in S phase.
Cells were then synchronized with aphidicolin at the
G1/S interface, and released by removing the drug. Both
exogenous and endogenous SMCX had very high upregu-
lation in the chromatin fraction after entry into S phase
(Figure 3B, C). We thus conclude that SMCX is present in
chromatin mainly in S phase, which correlates with the
expression pattern of PCNA.
Discussion
SMCX/JARID1C is a recently discovered H3K4 demethy-
lase, which belongs to a family of JARID1 proteins that
also contains the demethylases SMCY (JARID1D), RBP2
(JARID1A) and PLU1 (JARID1C). These two latter
demethylases share SMCX preferences for H3K4me3 and
H3K4me2 [8]. However, the SMCX gene was identified
before the discovery of its demethylase activity and its
mutations were associated with X-linked mental retarda-
tion (XMLR), which affects 1 in 500 males. This gene is
also one of the few that escape from inactivation of the
mammalian X chromosome [9]. A novel mutation was
found recently in the SMCX gene of a patient with ASD,
and it may be responsible for producing the autism pheno-
type in this patient [15]. It was thus thought that the
SMCX role is restricted to neurons and, it was consistently
shown that SMCX expression during zebrafish develop-
ment is highest in the brain, and that SMCX is required
for neuron survival and dendritic development [8].
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Nevertheless, other results argue for an additional role
of SMCX in non-neuronal cells. SMCX was found to be
ubiquitously expressed during early mammalian develop-
ment [8], and it is also involved in E2-mediated repres-
sion of papillomavirus oncogenes. In addition, SMCX
levels were found to be increased in prostate and semi-
noma cancers and to be absent in renal carcinomas
[24,25]. Finally, SMCX was found in a protein complex
with REST, which represses transcription of neuronal
genes in non-neuronal tissues, and was recently found to
play a tumor suppressor role in breast cancer by suppres-
sion of the oncogenic TAC1 (tachykinin, precursor 1)
protein [7,26]. These results support a role for SMCX in
non-neuronal, dividing cells.
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Figure 6 Profliferating cell nuclear antigen-interaction protein motif (PIP box) boxes in SMCX (Smcy homolog, X-linked (mouse)) and
G9a. PIP boxes were identified as described in Methods. (A) SMCX; (B) G9a; (C) comparison of SMCX, G9a and WRN (Werner
syndrome protein) PIP boxes. SMCX domains: BRIGHT = DNA binding domain, JmjC = JmjC domain, JmjN = JmjN domain, PHD1 = PHD-
finger 1, PHD2 = PHD-finger 2, Zn = zinc finger. G9a domains: ANK = Ankyrin repeats domain, Pre-set = Pre-set motif, Post-set = Post-set
domain, Set = Set domain.
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SMCX is one of the few known H3K4 demethylases, and
H3K4 methylation is a crucial epigenetic modification that
regulates both transcription and the DNA-damage
response [27,28]. In addition, SMCX has been shown to
play a role in disease development (see above). It is thus
crucial to understand the cellular regulation of SMCX
function. Unfortunately, very little is known about how
this gene and protein are regulated. Some information can
be inferred from yeast, which contains the SMCX homo-
log, Jhd2 [29]. Levels of Jhd2 protein in yeast are modu-
lated through polyubiquitylation by the E3 ubiquitin ligase
Not4 and its turnover is mediated by the proteasome [30].
Polyubiquitin-mediated degradation of Jhd2 controls in
vivo H3K4 trimethylation and gene-expression levels.
Human NOT4 can also polyubiquitylate JARID1C/SMCX,
a human homolog of Jhd2, suggesting that this is probably
a conserved mechanism [30].
In this study, we showed that SMCX entry into chro-
matin depends on PCNA, which is found in complex
with SMCX. SMCX contains a PIP box, whose amino
acids are important for the association of SMCX with
PCNA and chromatin. PCNA is expressed by dividing
cells, predominantly in the S phase of the cell cycle, when
it associates with replication forks [31]. Our results sup-
port a role for SMCX in dividing cells, in addition to neu-
rons, possibly in the establishment and maintenance of
H3K4 methylation patterns during and after the S phase
of the cell cycle.
Conclusions
In summary, our data indicate that the intracellular traf-
ficking of SMCX is controlled by its association with
PCNA.
Additional material
Additional file 1: Figure S1. Effects of G9a knockdown on chromatin
levels of SMCX (Smcy homolog, X-linked (mouse)). 293T cells were
transfected with the SMCX-encoding plasmid and anti-G9a, anti-
proliferating cell nuclear antigen, or control small interfering RNA. Two
days after transfection, cells were harvested. The chromatin fraction was
separated from the rest of the lysate, and analyzed by western blotting.
List of abbreviations
DMEM: Dulbecco’s modified Eagle’s medium; DAPI: 4’,6-diamidino-2-
phenylindole; FBS: fetal bovine serum; GADPH: glyceraldehyde 3-phosphate
dehydrogenase; PBS: phosphate-buffered saline; SDS-PAGE: sodium dodecyl
sulphate polyacrylamide gel electrophoresis
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